23rd International AIDS Conference: Virtual

Watch this short video highlight to hear expert insights on the latest updates from AIDS 2020: Virtual on weight changes during ART and PrEP.

Jürgen K. Rockstroh, MD Released: August 17, 2020

Patients switching from TDF to TAF in the OPERA cohort experienced an increase in weight of about 2 kg over 9 months, but then the rate of weight gain stabilized to be similar to the rate observed before the switch. How should these data inform ART decisions in clinical practice?

Daniel R. Kuritzkes, MD Released: August 11, 2020

Since the introduction of daily oral FTC/TDF PrEP 8 years ago, new options have emerged and promising new data on investigational strategies that do not require daily oral dosing suggest that highly effective HIV prevention modalities will continue to expand. Here’s my take on new PrEP data from AIDS 2020: Virtual.

Eric S. Daar, MD Released: August 19, 2020

Hear insights from Chloe Orkin, MBChB, FRCP, MD, on some of the most important new data reported at AIDS 2020: Virtual, including the use of current ART regimens in principal populations, metabolic outcomes during ART, HIV and COVID-19, investigational ART strategies, and HIV prevention.

Chloe Orkin, MBChB, FRCP, MD Released: August 14, 2020

In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important conference, including new data on the following hot topics: current ART in principal populations, including older patients and women who become pregnant; metabolic outcomes during ART; HIV and COVID-19; investigational ART strategies; and HIV prevention.

Babafemi Taiwo, MBBS David A. Wohl, MD Released: July 24, 2020